Search Within

Serge K. Lyashchenko

Formats
  1. Journal Article (55)
  2. Meeting Abstract (45)
  3. Review (4)
  4. Book Section (3)
  5. Correspondence (1)
Groups
  1. Radiochemistry and Imaging Sciences Service (108)
  2. Radiology, Department of (108)
  3. GSK Faculty (97)
  4. Molecular Imaging and Therapy Service (89)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (82)
  6. Center for Pancreatic Cancer Research (81)

More Groups

People
  1. Jason Lewis (75)
  2. Neeta Pandit-Taskar (52)
  3. Steven Larson (46)
  4. Jorge Carrasquillo (36)
  5. Joseph O'Donoghue (33)
  6. Pat Zanzonico (32)

More People

Years
  1. 2025 (2)
  2. 2024 (14)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (2)
  6. 2020 (11)

More Years

Publications
  1. Journal of Nuclear Medicine (28)
  2. Journal of Clinical Oncology (17)
  3. European Journal of Nuclear Medicine and Molecular Imaging (6)
  4. Neuro-Oncology (6)
  5. Clinical Cancer Research (5)
  6. Pediatric Blood and Cancer (5)

More Publications

Publishers
  1. Society of Nuclear Medicine (28)
  2. American Society of Clinical Oncology (17)
  3. Springer (11)
  4. Oxford University Press (9)
  5. American Association for Cancer Research (7)
  6. Wiley Periodicals, Inc (5)

More Publishers

Results (108)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and feasibility of PARP1/2 imaging with (18)F-PARPi in patients with head and neck cancer
    Journal Article

    Schöder, H.; De Souza Franca, P. D.; Nakajima, R.; Burnazi, E.; Roberts, S.; Brand, C.; Grkovski, M.; Mauguen, A.; Dunphy, M. P.; Ghossein, R. A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Identification of HER2-positive metastases in patients with HER2-negative primary breast cancer by using HER2-targeted (89)Zr-pertuzumab PET/CT
    Journal Article

    Ulaner, G. A.; Carrasquillo, J. A.; Riedl, C. C.; Yeh, R.; Hatzoglou, V.; Ross, D. S.; Jhaveri, K.; Chandarlapaty, S.; Hyman, D. M.; Zeglis, B. M.; more...
    Radiology (2020)

    Fulltext@MSK | Save
  • (11)C-choline PET/CT in recurrent prostate cancer: Retrospective analysis in a large U.S. patient series
    Journal Article

    Michaud, L.; Touijer, K. A.; Mauguen, A.; Zelefsky, M. J.; Morris, M. J.; Lyashschenko, S. K.; Durack, J. C.; Humm, J. L.; Weber, W. A.; Schöder, H.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • CD38-targeted immuno-PET of multiple myeloma: From xenograft models to first-in-human imaging
    Journal Article

    Ulaner, G. A.; Sobol, N. B.; O'Donoghue, J. A.; Kirov, A. S.; Riedl, C. C.; Min, R.; Smith, E.; Carter, L. M.; Lyashchenko, S. K.; Lewis, J. S.; more...
    Radiology (2020)

    Fulltext@MSK | Save
  • First-in-humans imaging with (89)Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: Preliminary pharmacokinetics, biodistribution, and lesion targeting
    Journal Article

    Pandit-Taskar, N.; Postow, M. A.; Hellmann, M. D.; Harding, J. J.; Barker, C. A.; O'Donoghue, J. A.; Ziolkowska, M.; Ruan, S.; Lyashchenko, S. K.; Tsai, F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Hyperpolarized MRI of human prostate cancer reveals increased lactate with tumor grade driven by monocarboxylate transporter 1
    Journal Article

    Granlund, K. L.; Tee, S. S.; Vargas, H. A.; Lyashchenko, S. K.; Reznik, E.; Fine, S.; Laudone, V.; Eastham, J. A.; Touijer, K. A.; Reuter, V. E.; more...
    Cell Metabolism (2020)

    Fulltext@MSK | Save
  • Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan
    Journal Article

    Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Biodistribution and dosimetry of intraventricularly administered (124)I-omburtamab in patients with metastatic leptomeningeal tumors
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P. B.; Kramer, K.; Grkovski, M.; Fung, E. K.; Shi, W.; Zhang, Z.; Lyashchenko, S. K.; Fung, A. M.; Pentlow, K. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Retooling a blood-based biomarker: Phase I assessment of the high-affinity CA19-9 antibody HuMAB-5B1 for immuno-PET imaging of pancreatic cancer
    Journal Article

    Lohrmann, C.; O'Reilly, E. M.; O'Donoghue, J. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Lyashchenko, S. K.; Ruan, S.; Teng, R.; Scholz, W.; Maffuid, P. W.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save